Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bangalore 560029, Karnataka, India.
Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore 560029, Karnataka, India.
J Chem Neuroanat. 2019 Jan;95:13-28. doi: 10.1016/j.jchemneu.2018.02.004. Epub 2018 Feb 27.
In eukaryotes, mitochondrial complex I (NADH: ubiquinone oxidoreductase; CI) is central to oxidative phosphorylation (OXPHOS). Mammalian CI is a 45 subunit complex that forms supercomplexes with other OXPHOS complexes. Since CI defects are associated with aging and neurodegeneration, it is pertinent to understand its structure-function relationship. Although genetic mutations could lower CI activity causing mitochondrial dysfunction in several pathologies, post-translational modifications (PTMs) have emerged as a key mechanism contributing to altered CI activity. Among non-oxidative PTMs, protein phosphorylation is the most intricate regulatory mechanism controlling CI structure and function during normal physiology, aging and neurodegeneration. To comprehend this, we carried out a comprehensive bioinformatics analysis of protein phosphorylation of human CI subunits using software-based prediction of phosphorylation (phospho) sites and associated kinases. Phosphorylation was higher among core subunits and active domains of the complex. Among the subunits, NDUFS1 displayed significantly higher number as well as percent phospho sites compared to others. Analysis of the subunits containing iron-sulfur (Fe-S) cluster, NADH and FMN binding sites and quinone binding sites indicated the presence of phospho sites in close proximity to the binding sites of these cofactors with potential functional implications. Phosphoproteomics experiment in rat and human muscle mitochondria identified specific phospho sites in CI subunits, thereby validating the bioinformatic analysis. Molecular modeling of CI subunits indicated structural implications following phosphorylation. We surmise that protein phosphorylation, a transient and regulatory event could influence the structure-function relationship of CI thereby impinging on bioenergetics and ultimately contributing to aging and neurodegeneration.
在真核生物中,线粒体复合物 I(NADH:泛醌氧化还原酶;CI)是氧化磷酸化(OXPHOS)的核心。哺乳动物 CI 是一个由 45 个亚基组成的复合物,它与其他 OXPHOS 复合物形成超复合物。由于 CI 缺陷与衰老和神经退行性变有关,因此了解其结构-功能关系至关重要。尽管遗传突变可能会降低 CI 活性,导致几种病理学中的线粒体功能障碍,但翻译后修饰(PTMs)已成为导致 CI 活性改变的关键机制。在非氧化 PTMs 中,蛋白质磷酸化是控制 CI 结构和功能在正常生理、衰老和神经退行性变过程中最复杂的调节机制。为了理解这一点,我们使用基于软件的磷酸化(磷酸化)位点和相关激酶预测,对人 CI 亚基的蛋白质磷酸化进行了全面的生物信息学分析。磷酸化在核心亚基和复合物的活性域中较高。在这些亚基中,NDUFS1 显示出明显更高数量和百分比的磷酸化位点。对含有铁硫(Fe-S)簇、NADH 和 FMN 结合位点和醌结合位点的亚基的分析表明,这些辅助因子的结合位点附近存在磷酸化位点,具有潜在的功能意义。大鼠和人肌肉线粒体的磷酸化蛋白质组学实验鉴定了 CI 亚基中的特定磷酸化位点,从而验证了生物信息学分析。CI 亚基的分子建模表明磷酸化后的结构影响。我们推测,蛋白质磷酸化是一种短暂的调节事件,可能会影响 CI 的结构-功能关系,从而影响生物能量学,并最终导致衰老和神经退行性变。